Volunteer Assignments and Opportunities: Difference between revisions

|Myeloproliferative Neoplasms (MPN)||'''''Overview'''''|| ||Fabiola Quintero-Rivera (FQR)

|Chronic Myeloid Leukemia (CML), BCR-ABL1-Positive||Disease

|Chronic Neutrophilic Leukemia (CNL)||Disease

|Polycythaemia Vera (PV)||Disease

|Primary Myelofibrosis (PMF)||Disease

|Essential Thrombocythaemia (ET)||Disease

|Chronic Eosinophilic Leukemia, Not Otherwise Specified||Disease

|Myeloproliferative Neoplasm (MPN), Unclassifiable||Disease

|Mastocytosis||'''''Overview'''''|| ||FQR

|Cutaneous Mastocytosis||Disease

|Systemic Mastocytosis||Disease

|Mast Cell Sarcoma||Disease

|Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2||'''''Overview'''''|| ||FQR

|Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement||Disease|| ||FQR

|Myeloid/Lymphoid Neoplasms with PDGFRB Rearrangement||Disease|| ||FQR

|Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement||Disease|| ||FQR

|Myeloid/Lymphoid Neoplasms with PCM1-JAK2||Disease|| ||FQR

|Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)||'''''Overview'''''|| ||FQR

|Chronic Myelomonocytic Leukemia (CMML)||Disease|| ||FQR

|Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease|| ||FQR

|Juvenile Myelomonocytic Leukemia (JMML)||Disease|| ||FQR

|Myelodysplastic/Myeloproliferative Neoplasms with Ring  Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)||Disease|| ||FQR

|Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease|| ||FQR

|Myelodysplastic Syndromes (MDS)||'''''Overview'''''|| ||FQR

|Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia||Disease|| ||FQR

|Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)||Disease|| ||FQR

|Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease|| ||FQR

|Myelodysplastic syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with Multilineage Dysplasia||Disease|| ||FQR

|Myelodysplastic Syndrome (MDS) with Excess Blasts||Disease|| ||FQR

|Myelodysplastic Syndrome (MDS) with Isolated del(5q)||Disease|| ||FQR

|Myelodysplastic Syndrome (MDS), Unclassifiable||Disease|| ||FQR

|Refractory Cytopenia of Childhood||Disease|| ||FQR

|Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms||'''''Overview'''''|| ||Jennelle Hodge (JH)

|Myeloid Neoplasms with Germline Predisposition||'''''Overview'''''|| ||JH

|Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease|| ||JH

|Myeloid Neoplasms with Germline DDX41 Mutation||Disease|| ||JH

|Myeloid Neoplasms with Germline RUNX1 Mutation||Disease|| ||JH

|Myeloid Neoplasms with Germline ANKRD26 Mutation||Disease|| ||JH

|Myeloid Neoplasms with Germline ETV6 Mutation||Disease|| ||JH

|Myeloid Neoplasms with Germline GATA2 Mutation||Disease|| ||JH

|Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities||'''''Overview'''''|| ||JH

|Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease|| ||JH

|Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease|| ||JH

|Acute Promyelocytic Leukemia (APL) with PML-RARA||Disease|| ||JH

|Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease|| ||JH

|Acute Myeloid Leukemia (AML) with t(6;9)(p23;q34.1); DEK-NUP214||Disease|| ||JH

|Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease|| ||JH

|Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease|| ||JH

|Acute Myeloid Leukemia (AML) with BCR-ABL1||Disease|| ||JH

|Acute Myeloid Leukemia (AML) with Mutated NPM1||Disease|| ||JH

|Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA||Disease|| ||JH

|Acute Myeloid Leukemia (AML) with Mutated RUNX1||Disease|| ||JH

|Acute Myeloid Leukemia (AML), Not Otherwise Specified||'''''Overview'''''|| ||JH

|Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease|| ||JH

|Acute Myeloid Leukemia (AML) without Maturation||Disease|| ||JH

|Acute Myeloid Leukemia (AML) with Maturation||Disease|| ||JH

|Acute Myelomonocytic Leukemia||Disease|| ||JH

|Acute Monoblastic and Monocytic Leukemia||Disease|| ||JH

|Pure Erythroid Leukemia||Disease|| ||JH

|Acute Megakaryoblastic Leukemia (AMKL)||Disease|| ||JH

|Acute Basophilic Leukemia||Disease|| ||JH

|Acute Panmyelosis with Myelofibrosis||Disease|| ||JH

|Myeloid Proliferations Associated with Down Syndrome||'''''Overview'''''|| ||JH

|Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome||Disease|| ||JH

|Myeloid Leukemia Associated with Down Syndrome||Disease|| ||JH

|Acute Leukemias of Ambiguous Lineage||'''''Overview'''''|| ||JH

|    Mixed Phenotype Acute Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease|| ||JH

|Precursor Lymphoid Neoplasms||'''''Overview'''''|| ||Yassmine Akkari (YA)

|B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities||'''''Overview'''''|| ||YA

|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1     ||Disease|| ||YA

|T-Lymphoblastic Leukemia/Lymphoma||'''''Overview'''''|| ||YA

|Mature B-Cell Neoplasms||'''''Overview'''''|| ||Snehal Patel (SP)

|Splenic B-cell Lymphoma/Leukemia, Unclassifiable||'''''Overview'''''|| ||SP

|Heavy Chain Diseases||'''''Overview'''''|| ||SP

|    Monoclonal  Immunoglobulin Deposition Diseases||'''''Overview'''''|| ||SP

|Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome||'''''Overview'''''|| ||SP